Skin surface markers for stereotactic body radiation therapy of sternal metastasis.

Hemmatazad, Hossein; Schmidhalter, Daniel; Eliçin, Olgun; Aebersold, Daniel; Herrmann, Evelyn (2019). Skin surface markers for stereotactic body radiation therapy of sternal metastasis. Reports of practical oncology and radiotherapy, 24(4), pp. 322-324. Elsevier 10.1016/j.rpor.2019.05.005

Text 1-s2.0-S1507136719300422-main.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (366kB)

Stereotactic body radiation therapy is an effective and safe treatment modality for bone metastasis which allows clinicians to accurately target lesions to high doses while minimizing dose to organs at risk. The commercially available CyberKnife Xsight™ Spine Tracking System (Accuray, Inc., Sunnyvale, CA) tracks static skeletal structures and eliminates the need for implanted fiducial markers (FMs). However, the Xsight™ Spine Tracking system is not appropriate for bone metastases outside the spine, which are moving due to respiration and typically, FMs have to be implanted close to the lesion. These FMs will be used to track the dynamic target. For targets close to the surface, non-invasive fixation of the FMs to the patient's skin could be an option.

Interest & Impact

Downloads

1 since deposited on 31 Jul 2019
0 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item